Research
Ketamine Offers Rapid Relief in Obsessive-Compulsive Disorder: A Controlled Crossover Trial
A pivotal study published in Neuropsychopharmacology presents the first randomized, controlled crossover trial demonstrating that a single dose of ketamine can have rapid anti-obsessional effects in adults with obsessive-compulsive disorder (OCD). This groundbreaking research, involving 15 drug-free participants with near-constant obsessions, shows that ketamine, a non-competitive N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, can provide significant improvement in OCD symptoms. The trial used a double-blind, placebo-controlled design, where participants received infusions of both saline and ketamine (0.5 mg/kg). Results revealed a notable reduction in OCD symptoms during and after ketamine infusion, with half of the participants meeting criteria for treatment response a week post-infusion, marking a significant advancement in OCD treatment research.
Studies & Research
Ketamine in Major Depressive and Bipolar Disorder: A Meta-Analysis Review
Ketamine's Immediate and Extended Impact on Suicidality: A Medical Inpatient Study
Ketamine's Role in Reducing Alcohol Consumption: Targeting Maladaptive Reward Memories
Exploring Ketamine's Impact on Anxious Depression: MRI Insights into Brain Activity and Antidepressant Effects
Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study
Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study
Late-Life Depression: Determining Optimal Ketamine Doses
Disclaimers
Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules
Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.
Questions?
(310) 280-4440
care@ketamineuplift.com
4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292
© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy
Research
Ketamine Offers Rapid Relief in Obsessive-Compulsive Disorder: A Controlled Crossover Trial
A pivotal study published in Neuropsychopharmacology presents the first randomized, controlled crossover trial demonstrating that a single dose of ketamine can have rapid anti-obsessional effects in adults with obsessive-compulsive disorder (OCD). This groundbreaking research, involving 15 drug-free participants with near-constant obsessions, shows that ketamine, a non-competitive N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, can provide significant improvement in OCD symptoms. The trial used a double-blind, placebo-controlled design, where participants received infusions of both saline and ketamine (0.5 mg/kg). Results revealed a notable reduction in OCD symptoms during and after ketamine infusion, with half of the participants meeting criteria for treatment response a week post-infusion, marking a significant advancement in OCD treatment research.
Studies & Research
Ketamine in Major Depressive and Bipolar Disorder: A Meta-Analysis Review
Ketamine's Immediate and Extended Impact on Suicidality: A Medical Inpatient Study
Ketamine's Role in Reducing Alcohol Consumption: Targeting Maladaptive Reward Memories
Exploring Ketamine's Impact on Anxious Depression: MRI Insights into Brain Activity and Antidepressant Effects
Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study
Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study
Late-Life Depression: Determining Optimal Ketamine Doses
Disclaimers
Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules
Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.
Questions?
(310) 280-4440
care@ketamineuplift.com
4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292
© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy